IL-17
Showing 1 - 25 of 9,592
Axial Spondyloarthritis Trial in Nîmes, Montpellier, Tours (Daily dietary supplementation with Fibruline, Anti-IL-17 therapy)
Recruiting
- Axial Spondyloarthritis
- Daily dietary supplementation with Fibruline
- Anti-IL-17 therapy
-
Nîmes, Gard, France
- +2 more
Apr 19, 2023
Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis
Not yet recruiting
- Rheumatoid Arthritis
- (no location specified)
Oct 4, 2022
Host Microbiota and Il-17 in Favoring Multiple Myeloma
Recruiting
- Multiple Myeloma
-
Milan, Milano, ItalyIRCCS Ospedale San Raffaele
Jan 26, 2023
Acne Vulgaris, Vitamin D Trial in Jakarta Pusat (combination oral and topical vitamin D, oral and topical cholecalciferol, oral
Enrolling by invitation
- Acne Vulgaris
- Vitamin D
- combination oral and topical vitamin D
- +2 more
-
Jakarta Pusat, DKI Jakarta, IndonesiaRSUPN Dr. Cipto Mangunkusumo
Mar 4, 2023
IL17 Rate and Spondyloarthritis
Recruiting
- Spondylarthritis
- Blood sample
-
Nice, FranceCHU de NICE
Oct 21, 2022
COVID-19 Respiratory Infection Trial in Sohag (laboratory test)
Completed
- COVID-19 Respiratory Infection
- laboratory test
-
Sohag, EgyptSohag University
Oct 24, 2022
Psoriasis Trial in Shanghai, Kunming (Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection, Placebo)
Active, not recruiting
- Psoriasis
- Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection
- Placebo
-
Shanghai, Shanghai, China
- +2 more
Nov 7, 2022
Patients Receiving Biotherapies Targeting IL-23/IL-17 Axis in
Recruiting
- Psoriasis
- Blood sample
- +2 more
-
Paris, Ile De France, FranceLars ROGGE
Oct 6, 2022
Idiopathic Subglottic Stenosis Trial in New Haven (Taltz)
Not yet recruiting
- Idiopathic Subglottic Stenosis
-
New Haven, ConnecticutYale New Haven Hospital
Jul 21, 2022
Il-17 and Il-18 in Aggressive Periodontitis
Completed
- Aggressive Periodontitis
- non surgical periodontal therapy
-
Cairo, EgyptFaculty of oral and dental medicine,FUE, Cairo,Egypt
Mar 30, 2022
Long COVID, POTS - Postural Orthostatic Tachycardia Syndrome, Autonomic Dysfunction Trial (IL-6, cytokines (IL-17, and IFN-?),
Not yet recruiting
- Long COVID
- +2 more
- IL-6
- +2 more
- (no location specified)
Sep 6, 2023
Psoriasis Vulgaris, UVB Phototherapy Burn Trial in Qina (Serum Interleukin 17 levels, NB-UVB)
Completed
- Psoriasis Vulgaris
- UVB Phototherapy Burn
- Serum Interleukin 17 levels
- NB-UVB
-
Qinā, Qena, EgyptSouth Valley University
Dec 9, 2022
Periodontitis Trial (No intervention was applied to the groups the samples will be collected in terms of the diagnosis
Not yet recruiting
- Periodontitis
- No intervention was applied to the groups the samples will be collected in terms of the diagnosis (periodontitis, healthy)
- (no location specified)
Mar 31, 2022
Psoriasis Trial in Shanghai (608 Q2W, 608 Q4W, Placebo)
Not yet recruiting
- Psoriasis
- 608 Q2W
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Huanshan Hospital Fudan University
Sep 8, 2022
Obstructive Sleep Apnea and Idiopathic Pulmonary Fibrosis
Recruiting
- OSA,IPF
- IL-17A,S100A8
-
Tianjin, ChinaTianjin Medical University General Hospital
Apr 20, 2023
Periodontitis, Periodontal Diseases, Smoking Trial in Ankara (Non-surgical periodontal treatment)
Completed
- Periodontitis
- +3 more
- Non-surgical periodontal treatment
-
Ankara, Turkey
- +1 more
Mar 15, 2022
IL-17, TNF-alpha, RANKL Levels in Gingival Cervicular Fluid
Not yet recruiting
- Apical Periodontitis
- The teeth diagnosed with chronic apical periodontitis
- (no location specified)
Feb 1, 2022
Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))
Withdrawn
- Primary Sjogren's Syndrome
- tibulizumab (LY3090106)
-
Palo Alto, CaliforniaStanford University
Jan 12, 2022
Mouth Diseases, Periodontal Inflammation, Periodontal Diseases Trial in Antalya (GCF obtaining, Saliva Obtaining, Serum
Completed
- Mouth Diseases
- +2 more
- GCF obtaining
- +2 more
-
Antalya, TurkeyAkdeniz University Faculty of Dentistry
Jun 29, 2022
IL17 in Systemic Lupus Erythematosus Patients: Association With
Not yet recruiting
- Systemic Lupus Erythematosus
- Serum level of IL-17
-
Sohag, EgyptSohag University Hospital
Sep 12, 2021
Inflammatory Markers in Chronic Periodontitis Patients
Completed
- Aggressive Periodontitis
- non surgical periodontal therapy
-
Cairo, EgyptFuture university in Egypt
Mar 16, 2022
IL-17+ CD8 T Cells in Cancer Patients Trial in Taichung
Completed
- IL-17+ CD8 T Cells in Cancer Patients
-
Taichung, TaiwanChina Medical University Hospital
Jul 27, 2021
Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)
Completed
- Covid19
- Ixekizumab
- +3 more
-
Ribeirão Preto, SP, Brazil
- +1 more
Jul 26, 2022
Autoimmune Disease Trial in Joondalup, Nedlands (SCT650C)
Not yet recruiting
- Autoimmune Disease
-
Joondalup, Western Australia, Australia
- +2 more
Jun 7, 2023